Elanco Animal Health Incorporated

19.13-0.7800-3.92%Vol 4.67M1Y Perf -32.90%
Aug 9th, 2022 16:00 DELAYED
BID18.70 ASK19.61
Open19.67 Previous Close19.91
Pre-Market- After-Market19.13
 - -  - -%
Target Price
26.57 
Analyst Rating
Moderate Buy 2.39
Potential %
38.89 
Finscreener Ranking
★★★+     52.34
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★+     52.93
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★+     48.00
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
3.00 
Earnings Rating
Strong Sell
Market Cap9.07B 
Earnings Date
8th Aug 2022
Alpha-0.02 Standard Deviation0.10
Beta0.86 

Today's Price Range

18.8619.83

52W Range

18.6435.00

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
2.42%
1 Month
-2.64%
3 Months
-8.84%
6 Months
-22.62%
1 Year
-32.90%
3 Years
-35.04%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ELAN19.13-0.7800-3.92
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
ProfitabilityValueIndustryS&P 500US Markets
56.30
-4.00
10.60
-6.60
-4.52
RevenueValueIndustryS&P 500US Markets
3.47B
7.32
15.21
10.33
Earnings HistoryEstimateReportedSurprise %
Q02 20220.260.3638.46
Q01 20220.350.362.86
Q04 20210.170.2123.53
Q03 20210.170.1911.76
Q02 20210.260.287.69
Q01 20210.230.3760.87
Q04 20200.090.1233.33
Q03 20200.120.138.33
Earnings Per EndEstimateRevision %Trend
6/2022 QR0.26-23.53Negative
9/2022 QR0.278.00Positive
12/2022 FY1.15-4.96Negative
12/2023 FY1.46-2.01Negative
Next Report Date-
Estimated EPS Next Report0.26
Estimates Count8
EPS Growth Next 5 Years %17.50
Volume Overview
Volume4.67M
Shares Outstanding474.11K
Shares Float444.16M
Trades Count33.79K
Dollar Volume89.41M
Avg. Volume5.62M
Avg. Weekly Volume7.89M
Avg. Monthly Volume4.34M
Avg. Quarterly Volume4.63M

Elanco Animal Health Incorporated (NYSE: ELAN) stock closed at 19.91 per share at the end of the most recent trading day (a 2.42% change compared to the prior day closing price) with a volume of 10.57M shares and market capitalization of 9.07B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 6080 people. Elanco Animal Health Incorporated CEO is Jeffrey N. Simmons.

The one-year performance of Elanco Animal Health Incorporated stock is -32.9%, while year-to-date (YTD) performance is -29.84%. ELAN stock has a five-year performance of %. Its 52-week range is between 18.64 and 35, which gives ELAN stock a 52-week price range ratio of 3.00%

Elanco Animal Health Incorporated currently has a PE ratio of -27.10, a price-to-book (PB) ratio of 1.25, a price-to-sale (PS) ratio of 2.73, a price to cashflow ratio of 24.60, a PEG ratio of 2.32, a ROA of -2.25%, a ROC of -1.18% and a ROE of -4.78%. The company’s profit margin is -4.52%, its EBITDA margin is 10.60%, and its revenue ttm is $3.47 Billion , which makes it $7.32 revenue per share.

Of the last four earnings reports from Elanco Animal Health Incorporated, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.26 for the next earnings report. Elanco Animal Health Incorporated’s next earnings report date is -.

The consensus rating of Wall Street analysts for Elanco Animal Health Incorporated is Moderate Buy (2.39), with a target price of $26.57, which is +38.89% compared to the current price. The earnings rating for Elanco Animal Health Incorporated stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Elanco Animal Health Incorporated has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Elanco Animal Health Incorporated has a Sell technical analysis rating based on Technical Indicators (ADX : 13.38, ATR14 : 0.68, CCI20 : -21.50, Chaikin Money Flow : 0.00, MACD : -0.38, Money Flow Index : 49.25, ROC : -3.35, RSI : 46.87, STOCH (14,3) : 54.51, STOCH RSI : 0.73, UO : 43.87, Williams %R : -45.49), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Elanco Animal Health Incorporated in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (33.33 %)
3 (42.86 %)
3 (37.50 %)
Moderate Buy
1 (11.11 %)
1 (14.29 %)
1 (12.50 %)
Hold
4 (44.44 %)
3 (42.86 %)
4 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (11.11 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.39
Moderate Buy
1.93
Moderate Buy
2.06

Elanco Animal Health Incorporated

Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Latin America, and the Asia Pacific with the highest revenue from the North America segment. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

CEO: Jeffrey N. Simmons

Telephone: +1 877 352-6261

Address: 2500 Innovation Way, Greenfield 46140, IN, US

Number of employees: 6 080

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

44%56%

Bearish Bullish

55%45%

Bearish Bullish

54%46%

TipRanks News for ELAN

Sun, 26 Jun 2022 07:29 GMT Elanco Animal Health (ELAN) Receives a Hold from Stifel Nicolaus

- TipRanks. All rights reserved.

News

Stocktwits